Newsroom

Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force

Mar 18, 2020

Inflammatix named to Fierce 15 MedTech list

Mar 9, 2020

New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis

Jan 10, 2020

Inflammatix raises $32M, plus a BARDA contract, for its point-of-care infection diagnostics

Jan 10, 2020

Inflammatix Raises $32M in Series C Financing

Jan 10, 2020

Genetic platform takes the guesswork out of catching infections

Dec 4, 2019

BARDA awards contract to Inflammatix for innovative diagnostic test systems

Nov 18, 2019

BARDA backs Inflammatix test to improve antibiotic use

Nov 15, 2019

Inflammatix Nabs $6M from BARDA to Develop POC Acute Infection Diagnostic

Nov 15, 2019

Inflammatix scores BARDA contract for infection tests

Nov 14, 2019

How $6 million could help a small Peninsula company spot deadly infections

Nov 14, 2019

Inflammatix Inks BARDA Contract for up to $72M

Nov 14, 2019

Inflammatix sepsis test scores FDA breakthrough device designation

Nov 28, 2023

Inflammatix Aims for 2024 Launch of 30-Minute Sepsis and Acute Infection Test

Nov 28, 2023

Your medical devices are getting smarter. Can the FDA keep them safe?

Oct 9, 2023

Inflammatix Checks off All the Right Boxes with Investors

Mar 19, 2021

Inflammatix nets $102M to advance its immune system tests for infectious diseases

Mar 16, 2021

Infection-detection system from Peninsula company scores $102M, aims to hit market this year

Mar 16, 2021

A Bright Future Ahead for Novel Markers of Infection

Dec 15, 2020

Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test

Oct 29, 2020

Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform

Oct 8, 2020